insights_auto
Why is GANX down 3.70%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$1.04
arrow_downward
-3.70%(-0.040) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
328.88K
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
328.88K
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
24/7 Wall St.
·
33 minutes ago
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
BigGo Finance
·
2 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
2 hours ago
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
Traders Union
·
15 minutes ago
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com